APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

DNA Vaccines

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

Selected research

Market Structure

Global DNA Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173985400319 December 2025183 pages

Choose your research edition.

Industry ResearchDNA Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Vaccines Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal DNA Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.

This report provides an overview of the global DNA Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of DNA Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DNA Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the DNA Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

DNA Vaccines Segment by Company

Merck

GSK

Sanofi

Zoties

Elanco

Boehringer-Ingelheim

Indian Immunologicals

Plumbline Life Sciences

DNA Vaccines Segment by Type

Recombinant Protein Vaccine

Gene-Based Vaccine

DNA Vaccines Segment by Application

Human

Animal

DNA Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the DNA Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of DNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of DNA Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of DNA Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. DNA Vaccines Industry Trends Table 2. DNA Vaccines Industry Drivers Table 3. DNA Vaccines Industry Opportunities and Challenges Table 4. DNA Vaccines Industry Restraints Table 5. Global DNA Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global DNA Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global DNA Vaccines Sales by Manufacturers (K Doses) & (2021-2026) Table 8. Global DNA Vaccines Sales Market Share by Manufacturers Table 9. Global DNA Vaccines Average Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 10. Global DNA Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global DNA Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global DNA Vaccines Manufacturers, Product Type & Application Table 13. Global DNA Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global DNA Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Recombinant Protein Vaccine Table 17. Major Manufacturers of Gene-Based Vaccine Table 18. Global DNA Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Doses) Table 19. Global DNA Vaccines Sales by Type (2021-2026) & (K Doses) Table 20. Global DNA Vaccines Sales by Type (2027-2032) & (K Doses) Table 21. Global DNA Vaccines Sales Market Share by Type (2021-2026) Table 22. Global DNA Vaccines Sales Market Share by Type (2027-2032) Table 23. Global DNA Vaccines Revenue by Type 2021 VS 2025 VS 2032 (K Doses) Table 24. Global DNA Vaccines Revenue by Type (2021-2026) & (K Doses) Table 25. Global DNA Vaccines Revenue by Type (2027-2032) & (K Doses) Table 26. Global DNA Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global DNA Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Human Table 29. Major Manufacturers of Animal Table 30. Global DNA Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Doses) Table 31. Global DNA Vaccines Sales by Application (2021-2026) & (K Doses) Table 32. Global DNA Vaccines Sales by Application (2027-2032) & (K Doses) Table 33. Global DNA Vaccines Sales Market Share by Application (2021-2026) Table 34. Global DNA Vaccines Sales Market Share by Application (2027-2032) Table 35. Global DNA Vaccines Revenue by Application 2021 VS 2025 VS 2032 (K Doses) Table 36. Global DNA Vaccines Revenue by Application (2021-2026) & (K Doses) Table 37. Global DNA Vaccines Revenue by Application (2027-2032) & (K Doses) Table 38. Global DNA Vaccines Revenue Market Share by Application (2021-2026) Table 39. Global DNA Vaccines Revenue Market Share by Application (2027-2032) Table 40. Global DNA Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Table 41. Global DNA Vaccines Sales by Region (2021-2026) & (K Doses) Table 42. Global DNA Vaccines Sales Market Share by Region (2021-2026) Table 43. Global DNA Vaccines Sales Forecasted by Region (2027-2032) & (K Doses) Table 44. Global DNA Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 45. North America DNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 46. North America DNA Vaccines Sales by Country (2021-2026) & (K Doses) Table 47. North America DNA Vaccines Sales by Country (2027-2032) & (K Doses) Table 48. Europe DNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 49. Europe DNA Vaccines Sales by Country (2021-2026) & (K Doses) Table 50. Europe DNA Vaccines Sales by Country (2027-2032) & (K Doses) Table 51. Asia Pacific DNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 52. Asia Pacific DNA Vaccines Sales by Country (2021-2026) & (K Doses) Table 53. Asia Pacific DNA Vaccines Sales by Country (2027-2032) & (K Doses) Table 54. South America, Middle East and Africa DNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 55. South America, Middle East and Africa DNA Vaccines Sales by Country (2021-2026) & (K Doses) Table 56. South America, Middle East and Africa DNA Vaccines Sales by Country (2027-2032) & (K Doses) Table 57. Global DNA Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global DNA Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 59. Global DNA Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 60. Global DNA Vaccines Revenue Market Share by Region (2021-2026) Table 61. Global DNA Vaccines Revenue Market Share by Region (2027-2032) Table 62. Merck Company Information Table 63. Merck Business Overview Table 64. Merck DNA Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Merck DNA Vaccines Product Portfolio Table 66. Merck Recent Development Table 67. GSK Company Information Table 68. GSK Business Overview Table 69. GSK DNA Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. GSK DNA Vaccines Product Portfolio Table 71. GSK Recent Development Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi DNA Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sanofi DNA Vaccines Product Portfolio Table 76. Sanofi Recent Development Table 77. Zoties Company Information Table 78. Zoties Business Overview Table 79. Zoties DNA Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Zoties DNA Vaccines Product Portfolio Table 81. Zoties Recent Development Table 82. Elanco Company Information Table 83. Elanco Business Overview Table 84. Elanco DNA Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Elanco DNA Vaccines Product Portfolio Table 86. Elanco Recent Development Table 87. Boehringer-Ingelheim Company Information Table 88. Boehringer-Ingelheim Business Overview Table 89. Boehringer-Ingelheim DNA Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Boehringer-Ingelheim DNA Vaccines Product Portfolio Table 91. Boehringer-Ingelheim Recent Development Table 92. Indian Immunologicals Company Information Table 93. Indian Immunologicals Business Overview Table 94. Indian Immunologicals DNA Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Indian Immunologicals DNA Vaccines Product Portfolio Table 96. Indian Immunologicals Recent Development Table 97. Plumbline Life Sciences Company Information Table 98. Plumbline Life Sciences Business Overview Table 99. Plumbline Life Sciences DNA Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Plumbline Life Sciences DNA Vaccines Product Portfolio Table 101. Plumbline Life Sciences Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. DNA Vaccines Distributors List Table 105. DNA Vaccines Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. DNA Vaccines Product Image Figure 2. Global DNA Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global DNA Vaccines Sales (2021-2032) & (K Doses) Figure 5. Global DNA Vaccines Average Price (US$/Dose) & (2021-2032) Figure 6. Global Top 5 and 10 DNA Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Recombinant Protein Vaccine Image Figure 9. Gene-Based Vaccine Image Figure 10. Global DNA Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 11. Global DNA Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global DNA Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global DNA Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 14. Global DNA Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global DNA Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Human Image Figure 17. Animal Image Figure 18. Global DNA Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 19. Global DNA Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global DNA Vaccines Sales Market Share by Application (2021-2032) Figure 21. Global DNA Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 22. Global DNA Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global DNA Vaccines Revenue Market Share by Application (2021-2032) Figure 24. North America DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 25. North America DNA Vaccines Sales Market Share by Country (2021-2032) Figure 26. U.S. DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 27. Canada DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 28. Mexico DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 29. Europe DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 30. Europe DNA Vaccines Sales Market Share by Country (2021-2032) Figure 31. Germany DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 32. France DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 33. U.K. DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 34. Italy DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 35. Netherlands DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 36. Asia Pacific DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 37. Asia Pacific DNA Vaccines Sales Market Share by Country (2021-2032) Figure 38. China DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 39. Japan DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 40. South Korea DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 41. Southeast Asia DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 42. India DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 43. Australia DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 44. South America, Middle East and Africa DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 45. South America, Middle East and Africa DNA Vaccines Sales Market Share by Country (2021-2032) Figure 46. Brazil DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 47. South Africa DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 48. Saudi Arabia DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 49. Turkey DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 50. Argentina DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 51. UAE DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 52. Egypt DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 53. Chile DNA Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 54. Global DNA Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global DNA Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America DNA Vaccines Revenue (2021-2032) & (US$ Million) Figure 57. North America DNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe DNA Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. Europe DNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific DNA Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific DNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa DNA Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa DNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. DNA Vaccines Value Chain Figure 65. Manufacturing Cost Structure Figure 66. DNA Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Protein Vaccine
  • Gene-Based Vaccine
Applications
  • Human
  • Animal
Companies covered
  • Merck
  • GSK
  • Sanofi
  • Zoties
  • Elanco
  • Boehringer-Ingelheim
  • Indian Immunologicals
  • Plumbline Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global DNA Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global DNA Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global DNA Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global DNA Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global DNA Vaccines Market Dynamics
  1. 2.1 DNA Vaccines Industry Trends
  2. 2.2 DNA Vaccines Industry Drivers
  3. 2.3 DNA Vaccines Industry Opportunities and Challenges
  4. 2.4 DNA Vaccines Industry Restraints
3 DNA Vaccines Market by Manufacturers
  1. 3.1 Global DNA Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global DNA Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global DNA Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global DNA Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global DNA Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global DNA Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global DNA Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global DNA Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 DNA Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 DNA Vaccines Tier 1, Tier 2, and Tier 3
4 DNA Vaccines Market by Type
  1. 4.1 DNA Vaccines Type Introduction
  2. 4.1.1 Recombinant Protein Vaccine
  3. 4.1.2 Gene-Based Vaccine
  4. 4.2 Global DNA Vaccines Sales by Type
  5. 4.2.1 Global DNA Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global DNA Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global DNA Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global DNA Vaccines Revenue by Type
  9. 4.3.1 Global DNA Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global DNA Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global DNA Vaccines Revenue Market Share by Type (2021-2032)
5 DNA Vaccines Market by Application
  1. 5.1 DNA Vaccines Application Introduction
  2. 5.1.1 Human
  3. 5.1.2 Animal
  4. 5.2 Global DNA Vaccines Sales by Application
  5. 5.2.1 Global DNA Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global DNA Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global DNA Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global DNA Vaccines Revenue by Application
  9. 5.3.1 Global DNA Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global DNA Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global DNA Vaccines Revenue Market Share by Application (2021-2032)
6 Global DNA Vaccines Sales by Region
  1. 6.1 Global DNA Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DNA Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global DNA Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global DNA Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America DNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America DNA Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe DNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe DNA Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific DNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific DNA Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa DNA Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa DNA Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global DNA Vaccines Revenue by Region
  1. 7.1 Global DNA Vaccines Revenue by Region
  2. 7.1.1 Global DNA Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global DNA Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global DNA Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global DNA Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America DNA Vaccines Revenue (2021-2032)
  8. 7.2.2 North America DNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe DNA Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe DNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific DNA Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific DNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa DNA Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa DNA Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck DNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck DNA Vaccines Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK DNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GSK DNA Vaccines Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi DNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi DNA Vaccines Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Zoties
  20. 8.4.1 Zoties Company Information
  21. 8.4.2 Zoties Business Overview
  22. 8.4.3 Zoties DNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zoties DNA Vaccines Product Portfolio
  24. 8.4.5 Zoties Recent Developments
  25. 8.5 Elanco
  26. 8.5.1 Elanco Company Information
  27. 8.5.2 Elanco Business Overview
  28. 8.5.3 Elanco DNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Elanco DNA Vaccines Product Portfolio
  30. 8.5.5 Elanco Recent Developments
  31. 8.6 Boehringer-Ingelheim
  32. 8.6.1 Boehringer-Ingelheim Company Information
  33. 8.6.2 Boehringer-Ingelheim Business Overview
  34. 8.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Boehringer-Ingelheim DNA Vaccines Product Portfolio
  36. 8.6.5 Boehringer-Ingelheim Recent Developments
  37. 8.7 Indian Immunologicals
  38. 8.7.1 Indian Immunologicals Company Information
  39. 8.7.2 Indian Immunologicals Business Overview
  40. 8.7.3 Indian Immunologicals DNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Indian Immunologicals DNA Vaccines Product Portfolio
  42. 8.7.5 Indian Immunologicals Recent Developments
  43. 8.8 Plumbline Life Sciences
  44. 8.8.1 Plumbline Life Sciences Company Information
  45. 8.8.2 Plumbline Life Sciences Business Overview
  46. 8.8.3 Plumbline Life Sciences DNA Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Plumbline Life Sciences DNA Vaccines Product Portfolio
  48. 8.8.5 Plumbline Life Sciences Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 DNA Vaccines Value Chain Analysis
  2. 9.1.1 DNA Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 DNA Vaccines Production Mode & Process
  6. 9.2 DNA Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 DNA Vaccines Distributors
  9. 9.2.3 DNA Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst